Showing results (361-370 of 398) with videos related to

Sort By:
Pageof 40
The Journal of Experimental Medicine|December 22, 1998
Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growthS E Pike, L Yao, K D Jones, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|December 8, 2016
Inpatient care of small and sick newborns in healthcare facilitiesS B Neogi, R Khanna, M Chauhan, et al.
Acta Paediatrica (Oslo, Norway : 1992)|October 1, 1996
Occurrence of diarrhoeal diseases in relation to infant feeding practices in a rural community in West Bengal, IndiaS K Mondal, P G Gupta, D N Gupta, et al.
Human Reproduction (Oxford, England)|November 23, 2006
Novel disulphide esters of carbothioic acid as potent, non-detergent spermicides with low toxicity to Lactobacillus and HeLa cells in vitroR K Jain, J P Maikhuri, S T V S Kiran Kumar, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 20, 2015
Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft DysfunctionG Gupta, A Regmi, D Kumar, et al.
Molecular Cell|January 15, 2000
Inhibition of FEN-1 processing by DNA secondary structure at trinucleotide repeatsC Spiro, R Pelletier, M L Rolfsmeier, et al.
The Journal of Experimental Medicine|March 2, 1999
Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cellsR Pieper, R E Christian, M I Gonzales, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 23, 2001
Pituitary adenylyl cyclase-activating polypeptide stimulates DNA synthesis but delays maturation of oligodendrocyte progenitorsM Lee, V Lelievre, P Zhao, et al.
Blood|September 25, 1999
Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growthS E Pike, L Yao, J Setsuda, et al.
Journal for Immunotherapy of Cancer|July 20, 2026
Frontline immunotherapy with response-guided subsequent treatment (FIRST) in cutaneous squamous cell carcinoma: a Bayesian causal analysis of dose intensity, early benefit, and treatment de-escalationDavid M Miller, Ross D Merkin, Howard L Kaufman, et al.
Pageof 40